If AI 2027 Is Right, Should Patients Wait 15 Years for Imminent Cures?
LaCaipirinha · reddit · 2026-09-23
A clinical-trials professional argues that if the AI 2027 forecast is even remotely accurate, AI could soon accelerate biomedical research far beyond the pace of existing regulatory structures.
Key points:
- AI is already revolutionizing drug discovery, but AI adoption in clinical trials is minimal — the gap is immense.
- Most of the 10-15 year drug approval timeline isn't spent actively testing in animals or humans; it's consumed by validation, regulation, and deployment processes.
- The bottleneck will soon shift from scientific discovery to validation and regulation: by the time one agent's ALS-slowing drug reaches market, another agent will have devised cures many times over.
- The post asks how society should handle potentially transformative medicines delayed by processes completely unready for AI's pace.
More from AGI Musings
- Eric Schmidt says pausing AI is impossible; critics counter humanity matters too — birchlse · 2026-09-23
- AI cracks 100+ open math problems but general-purpose physical AI remains missing — beffjezos · 2026-09-23
- Ben Todd calls out OpenAI's circular logic: automating AI research to defend against the superhacking AI it creates — ben_j_todd · 2026-09-23
- Extropic's beffjezos: everyone optimizes intelligence per dollar, not raw intelligence per second — beffjezos · 2026-09-23
- Researcher bets next-gen models at half the params will match first-gen SoTA — tokenbender · 2026-09-23
- Eric Weinstein: mathematicians complaining about AI in math aren't the Einsteins — tak3sh8 · 2026-09-23